×
Innovation in Psychiatric Drug Development: A Quantitative Analysis of FDA-Approved Psychiatric Drugs, 2012–2024 PDF
$ 40.00
Innovation in Psychiatric Drug Development: A Quantitative Analysis of FDA-Approved Psychiatric Drugs, 2012–2024 PDF quantity
$ 40.00
×
Methylphenidate Treatment for Cocaine Abusers With Adult Attention-Deficit/Hyperactivity Disorder: A Pilot Study PDF
$ 40.00
Methylphenidate Treatment for Cocaine Abusers With Adult Attention-Deficit/Hyperactivity Disorder: A Pilot Study PDF quantity
$ 40.00
×
Lifespan Persistence of ADHD: The Life Transition Model and Its Application PDF
$ 40.00
Lifespan Persistence of ADHD: The Life Transition Model and Its Application PDF quantity
$ 40.00
×
Relapse Prevention and Residual Symptoms: A Closer Analysis of Placebo-Controlled Continuation Studies With Escitalopram in Major Depressive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, and Obsessive-Compulsive Disorder PDF
$ 40.00
Relapse Prevention and Residual Symptoms: A Closer Analysis of Placebo-Controlled Continuation Studies With Escitalopram in Major Depressive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, and Obsessive-Compulsive Disorder PDF quantity
$ 40.00
×
Comorbid Substance Use Disorders Among Youth With Bipolar Disorder: Opportunities for Early Identification and Prevention PDF
$ 40.00
Comorbid Substance Use Disorders Among Youth With Bipolar Disorder: Opportunities for Early Identification and Prevention PDF quantity
$ 40.00
×
Gabapentin Reduces Alcohol Consumption and Craving: A Randomized, Double-Blind, Placebo-Controlled Trial PDF
$ 40.00
Gabapentin Reduces Alcohol Consumption and Craving: A Randomized, Double-Blind, Placebo-Controlled Trial PDF quantity
$ 40.00
×
Are Advanced Paternal Age and Point Mutation at Chromosome 4 Associated With Schizophrenia? PDF
$ 40.00
Are Advanced Paternal Age and Point Mutation at Chromosome 4 Associated With Schizophrenia? PDF quantity
$ 40.00
×
The THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction: Validation in Patients With Major Depressive Disorder PDF
$ 40.00
The THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction: Validation in Patients With Major Depressive Disorder PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart